Toward a More Nuanced Science Journalism
By Gina Maranto, Biopolitical Times guest contributor
| 05. 29. 2011
Last week, Chicago Tribune reporter Monica Eng wrote about the latest chapter in the debate over genetically modified foods: their unavoidable creep into spaces and places assumed to be GM-free. Eng's counterintuitive lede describes anti-GMO protestors improbably marching outside a Whole Foods – a sign of just how bad the situation has gotten, when even purveyors of organics can't guarantee untainted fare.
The online version features several sobering visuals: a graph showing the disquieting rise in GM soy and corn production over the last decade (such plants now represent 93% and 86% of the US harvest, respectively); a map highlighting states currently deliberating policies to label GM foods; a table listing some of the 40 countries that currently require such labeling. Eng summarizes the industry and environmental health arguments, provides the obligatory pro and con quotations, refers to a couple key surveys of public attitudes about GMOs, mentions some recent epidemiological work, and ends with a boilerplate statement from Monsanto proclaiming the utter adequacy of the status quo ante to ensure "food safety" as supported by "satisfied" experts in...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...